Genovate Biotechnology Co Ltd (4130) — Cash Flow Quality Index
Genovate Biotechnology Co Ltd (4130) has a Cash Flow Quality Index of -3.61x as of June 2025. Operating cash flow of NT$-26.50 Million is below net income of NT$7.34 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Genovate Biotechnology Co Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Genovate Biotechnology Co Ltd Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Genovate Biotechnology Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Genovate Biotechnology Co Ltd cash flow conversion.
Annual Cash Flow Quality Index for Genovate Biotechnology Co Ltd (2015–2025)
Year-by-year earnings quality comparison for Genovate Biotechnology Co Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.75x | NT$43.79 Million | NT$11.68 Million | ▲ +74.8% |
| 2024 | 2.14x | NT$55.11 Million | NT$25.70 Million | ▼ -25.8% |
| 2023 | 2.89x | NT$84.78 Million | NT$29.33 Million | ▲ +106.2% |
| 2021 | -46.40x | NT$-17.26 Million | NT$372.00K | ▼ -2163.6% |
| 2020 | 2.25x | NT$87.08 Million | NT$38.73 Million | ▲ +72.3% |
| 2019 | 1.30x | NT$44.43 Million | NT$34.05 Million | ▲ +20.0% |
| 2018 | 1.09x | NT$62.88 Million | NT$57.85 Million | ▲ +417.8% |
| 2017 | 0.21x | NT$31.27 Million | NT$148.97 Million | ▼ -88.3% |
| 2016 | 1.80x | NT$70.58 Million | NT$39.21 Million | ▲ +157.3% |
| 2015 | 0.70x | NT$32.53 Million | NT$46.49 Million | — |